Rybicki BA, Walewski JL, Maliarik MJ, Kian H., Iannuzzi MCThe BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites . Am J Hum Genet. 2005; 77:491-499.
2.
Shetty AK, Gedalia A.Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J. 2008; 6:16.
3.
Hunninghake GW, Costabel U., Ando M., et al. ATS/ERS/ WASOG statement of sarcoidosis.American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders . Sarcoidosis Vasc Diffuse Lung Dis. 1999;16: 149-173.
4.
Touitou I., Kone-Paut I.Autoinflammatory diseases. Best Pract Res Clin Rheumatol. 2008;22:811-829.
5.
Laghmari M., Skiker H., Boutimzine N., Daoudi R.Uveitis during the course of sarcoidosis in a child: difficult diagnosis of a case. Bull Soc Belge Ophtalmol. 2008;(307): 47-51.
6.
Gedalia A., Shetty AK, Ward KJ, Correa H., Heinrich S.Role of MRI in diagnosis of childhood sarcoidosis with fever of unknown origin . J Pediatr Orthop. 1997;17: 460-462.
7.
Gedalia A., Molina JF, Ellis GS Jr, Galen W., Moore C., Espinoza LRLow-dose methotrexate therapy for childhood sarcoidosis. J Pediatr. 1997;130:25-29.
8.
Marcille R., McCarthy M., Barton JW, Merten DF, Spock A.Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status . Chest. 1992;102: 1444-1449.
